AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06409000 — intervention group
Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Medical records reviewed
Study NCT06409000 — intervention group
Intervention type: PROCEDURE
Intervention: Three-Dimensional Imaging
Description: Undergo 3D surface scans
Study NCT05923749 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biatain Ag
Description: Biatain with silver
Study NCT05923749 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cutimed Siltec Sorbact
Description: comparator device
Study NCT05038163 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutrition Facts
Description: The nutritional information label for each beverage is enlarged.
Study NCT05038163 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text Warning
Description: The health risks of sugary beverages are communicated to subjects using words/text and simple images.
Study NCT05038163 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Graphic Warning
Description: The health risks of sugary beverages are communicated to subjects using a combination of words/text and graphic images/photographs.
Study NCT06205485 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Leucovorin
Description: 400 mg/m2
Study NCT06205485 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: 85 mg/m2 or 130 mg/m2 on day 1
Study NCT06205485 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoruracil
Description: bolus fluoruracil (optional) 400 mg, infusional fluorouracil 2,400 mg/m2
Study NCT06205485 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: 1,000 mg/m2 twice daily for 14 days
Study NCT06205485 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation
Description: 54 Gy (27-30 fractions)
Study NCT05215665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GEMOX Regimen
Description: Oxaliplatin 100mg/m2 IV d1 Q3W+ gemcitabine 1000mg/m2 IV d1/8 Q3W
Study NCT05215665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: 8/12mg PO QD continuously
Study NCT05215665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: 240mg IV d1 Q3W
Study NCT05384938 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Benralizumab
Description: Prospective, Single-arm Study to Assess the Safety of Fasenra® (Benralizumab) in Adult Patients of Severe Asthma with Eosinophilic Phenotype in India
Study NCT04869358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ofatumumab
Description: Ofatumumab 20 mg s.c. on days 1, 7, 14, week 4 and every 4 weeks thereafter
Study NCT04806373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cathflo Activase
Description: Cathflo Activase 4mg in 50ml normal saline given through chest pleural catheter
Study NCT04806373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Talc Slurry Pleurodesis
Description: Talc, 5 gm in 50 ml Normal Saline given through chest pleural catheter
Study NCT04806373 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Talc Slurry Pleurodesis
Description: Talc, 5 gm in 50 ml Normal Saline given through chest pleural catheter
Study NCT06036706 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning
Description: Patients receiving normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning (IMRT, VMAT, Tomotherapy...)
Study NCT06036706 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Hypo-fractionated stereotactic brain irradiation
Description: Patients receiving hypo-fractionated stereotactic brain irradiation
Study NCT06036706 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Normo-fractionated proton therapy brain irradiation
Description: Patients receiving normo-fractionated proton therapy brain irradiation
Study NCT06036706 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cognitive assessment by a trained neuropsychologis
Description: Participants without any meningioma, cancer history or neurological comorbidities will undergo cognitive assessment by a trained neuropsychologist, similarly as for patients
Study NCT06478342 — intervention group
Intervention type: PROCEDURE
Intervention: ablation
Description: Pulsed field ablation, MRI and TEE examinations (LA strain)
Study NCT06244992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTT-936
Description: Eligible patients will receive single-agent PTT-936 administered per orally (PO).
Study NCT06244992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination of PTT-936 and anti-PD-1/L1 therapy
Description: Eligible patients will receive combination treatment consisting of PTT-936 administered PO in combination with a Standard of Care (SOC) regimen of an anti-PD-1/L1 agent administered intravenously (IV).
Study NCT04902677 — intervention group
Intervention type: OTHER
Intervention: Cross-sectional
Description: No intervention
Study NCT04589650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alpelisib
Description: Adult participants (group 1) will receive 125 mg of alpelisib oral tablets once daily. Pediatric participants (Group 2: 6 to 17 years old) will receive 50 mg of alpelisib oral tablets once daily. Pediatric participants (Group 4: 2 to 5 years old) will receive 50 mg of alpelisib oral tablets once daily, Pediatric participants (Group 3: 0 to 5 years old) will receive alpelisib granules formulation with an age-dependent starting dose and maximum dose levels ranging from 20 mg every other day to 50 mg once daily. Pediatric participants (Group 5: 6 to 17 years old) will receive 125 mg of alpelisib oral tablets once daily.
Study NCT04589650 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Alpelisib
Description: Adult participants (group 1) will receive 125 mg of alpelisib oral tablets once daily. Pediatric participants (Group 2: 6 to 17 years old) will receive 50 mg of alpelisib oral tablets once daily. Pediatric participants (Group 4: 2 to 5 years old) will receive 50 mg of alpelisib oral tablets once daily, Pediatric participants (Group 3: 0 to 5 years old) will receive alpelisib granules formulation with an age-dependent starting dose and maximum dose levels ranging from 20 mg every other day to 50 mg once daily. Pediatric participants (Group 5: 6 to 17 years old) will receive 125 mg of alpelisib oral tablets once daily.
Study NCT04589650 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive matching placebo once daily up to week 16.
Study NCT04891562 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: interlimb coordination of the lower limbs and synchronization
Description: 4 sessions (2 descriptive sessions, 2 experimental sessions), each lasting around 60 minutes. The m-ABC2 test, The MBEMA-s, Kids BESTest, interlimb coordination and synchronization investigation (visit 3 and 4)
Study NCT04891562 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: interlimb coordination of the lower limbs and synchronization
Description: 4 sessions (2 descriptive sessions, 2 experimental sessions), each lasting around 60 minutes. The m-ABC2 test, The MBEMA-s, Kids BESTest, interlimb coordination and synchronization investigation (visit 3 and 4)
Study NCT06688422 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: incentive spirometry
Description: The study will have one intervention group of patients using incentive spirometry in addition to standard of care treatment, including chemo/radiation and immunotherapy maintenance. Patients will use the incentive spirometer 10 times (10 breaths) every hour they are awake. Patients will be asked to start using the incentive spirometer as soon as they are enrolled in the study. Patients will be asked to continue to use incentive spirometry daily, including the duration of chemoradiation and up to three months post-treatment.
Study NCT06619951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VC004 and Itraconazole
Description: A single dose of VC004 was administered in the period 1. and a single dose of VC004 and Itraconazole coadministration in the period 2.
Study NCT06619951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VC004 and rifampicin
Description: A single dose of VC004 was administered in the period 1. and a single dose of VC004 and rifampicin coadministration in the period 2.
Study NCT06685848 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hemanext ONE system
Description: Hypoxic red blood cells
Study NCT06685848 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional RBCs
Description: Conventional manufactured Red blood cells
Study NCT06729853 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAP-001
Description: a single oral dose of SAP-001
Study NCT06728202 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: A Horizontal Ridge Augmentation in Atrophic Maxillary Ridge
Description: Aiming to enhance bone volume (Quantity) in horizontal maxillary bone defects and density (Quality) , providing a viable solution for implant stability and long-term success.
Study NCT06728943 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ureteral dilatation
Description: Direct semi-rigid ureteroscopy will initially be attempted without endodilatation (KARL STORZ, 43 cm, 6°, 7 Fr.). On failure to advance the semi-rigid ureteroscope through the ureter, intra-ureteric instillation of 20 ml of aminophylline (250 mg/10 mL) through ureteric stent and another trial to pass the same scope will be done after 10 minutes of intra-ureteral aminophylline instillation.
Study NCT06727994 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Providing Genital Hygiene training
Description: After the informed consent of all participants in the study is obtained, pre-test data, Self-Care Power Scale and Genital Hygiene Behavior Scale will be collected face-to-face.~Genital Hygiene training will be given. Reminder training will be given 15 days, 1 month and 2 months after the training, and 1 month after the reminder training, the Self-Care Power Scale and Genital Hygiene Behavior Scale will be re-administered to women as a final test.
Study NCT06727760 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: massage
Description: The mothers in the massage group applied colic massage according to the Educational Colic Massage Checklist twice a day for 15-20 minutes each time for three weeks, when the baby was calm and during colic attacks.
Study NCT06727760 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: kangroo care
Description: The mothers in the kangaroo care group applied kangaroo care according to the Educational Kangaroo Care Checklist twice a day for three weeks for 15-20 minutes each time when the baby was calm and during colic attacks.
Study NCT06160336 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation
Description: Phase 1: Participants undergo a comprehensive assessment in a single experimental session (mapping session) aimed at mapping the regions and sensations that can be electrically stimulated. This mapping protocol is conducted on both the intact and amputated limbs.~Phase 2: This phase comprises a 4-week experimental protocol, including:~1. four mapping sessions conducted at the onset of each week, where the protocol is randomly applied to the participant's intact and amputated limb.~2. three stimulation sessions held over three consecutive days in the initial week to assess the participant's ability to discern stimuli of varying intensities.~3. ten sessions utilizing an end-effector gait rehabilitation robot, aiming to train the participant in walking using the proposed sensory feedback restoration system based on TENS under controlled and repeatable experimental conditions.
Study NCT05486416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK3486
Description: HSK3486 for induction of general anesthesia
Study NCT05486416 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Propofol for induction of general anesthesia
Study NCT06729580 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioural Activation
Description: 10-week standardized behavioural activation program.
Study NCT06727981 — intervention group
Intervention type: DRUG
Intervention: ICI plus Chemothearpy
Description: This intervention involves the administration of immune checkpoint inhibitors (ICIs) in combination with standard chemotherapy.
Study NCT06727981 — intervention group
Intervention type: DRUG
Intervention: Chemotherapy
Description: This intervention involves the administration of standard chemotherapy alone.
Study NCT06729281 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: kinesio tape
Description: The application of kinesio tape is a relatively new method, first developed in 1973 by Kenzo Kase in Japan, also known as elastic bandage, which has become popular in the last 10 years following announcements at major events such as the Olympic Games.
Study NCT06727487 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Basic recommendations
Description: Daily basis activity counseling by WHO recommendations
Study NCT06727487 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical exercise
Description: A complete program of active physical exercise of medium and high intensity
Study NCT06727487 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional advice
Description: A complete program of nutritional counseling
Study NCT06727487 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psycho-oncological support
Description: A program related with a patient Psycho-oncological follow-up
Study NCT06728358 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Molecular analyses
Description: Search for molecular alterations that correlate with patient prognosis
Study NCT06017934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Volunteer-led physical activity
Description: Participants will be assessed by the therapy team who will prescribe tailored activity and then liaise with the mobility volunteers, who will deliver the intervention. Participants who can mobilise independently will be encouraged to perform walking exercises, progressing their walking distance over set markers in the hospital (e.g., to the end of the bed and back; to the doorway and back; to the toilet and back). Participants who require assistance in mobility will perform bed (e.g., hip abduction, static quads), or chair exercises (e.g., ankle pumps, knee extension, arm raise), and will be progressed to performing walking exercises when their physical function improves. Volunteers will check with nursing staff that participants are safe to exercise before each activity session. Participants will receive the mobility sessions twice daily, starting upon recruitment and continuing until the day of discharge from hospital.
Study NCT05978141 — intervention group
Intervention type: OTHER
Intervention: Optional Blood Sample and Nail Sample
Description: Participants may provide optional research blood and nail samples for biobanking and future use
Study NCT06524765 — intervention group
Intervention type: OTHER
Intervention: Living conditions
Description: There are many patients with multi-resistant bacterial infections in intensive care units (ICU), making it possible for a great deal of these pathogens to exist in the ICU environment. The exposure factors in this study were ICU environment or daily living environment.
Study NCT04731519 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Continuous Identity Cognitive Therapy (CI-CT)
Description: CI-CT was developed as a manualized treatment integrating components of CBT and Acceptance and Commitment Therapy (ACT) with self-continuity and future-self related interventions to help Veterans develop a better present-to-the-future life story as a framework for increasing hopefulness, a sense of life meaning, empowerment, and an ability to attain future self-goals. The recovery oriented CI-CT for post acute suicidal episode Veterans includes eight components: 1) constructing a CI narrative, 2) mindfulness training, 3) life values identification, 4) developing a self-growth perspective, 5) identifying possible future selves - timelines, 6) connecting with the desired future self, 7) CI as context for current problems, and 8) moving toward the future self.
Study NCT04731519 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Continuous Identity Cognitive Therapy (CI-CT)
Description: CI-CT was developed as a manualized treatment integrating components of CBT and Acceptance and Commitment Therapy (ACT) with self-continuity and future-self related interventions to help Veterans develop a better present-to-the-future life story as a framework for increasing hopefulness, a sense of life meaning, empowerment, and an ability to attain future self-goals. The recovery oriented CI-CT for post acute suicidal episode Veterans includes eight components: 1) constructing a CI narrative, 2) mindfulness training, 3) life values identification, 4) developing a self-growth perspective, 5) identifying possible future selves - timelines, 6) connecting with the desired future self, 7) CI as context for current problems, and 8) moving toward the future self.
Study NCT04731519 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Health Education
Description: General Health Education a structured manualized group health education intervention previously developed by VISN 2 MIRECC investigators as a control condition for group psychotherapy RCTs. It has 12 1.5-hour weekly group sessions focusing on health and wellness topics such as Sleep, Physical Activity, Impact of Stress, Relaxation Techniques, Substance Use, Nutrition, Managing Daily Activities, Medication Benefits and Side Effects. GHE was chosen for the AC because it aligns in many respects with CI-CT (e.g., group format, length of sessions, similar expectations) while diverging in specific topics and skills targeted allowing for control of common factors like attention without causing confounding due to overlap in concepts
Study NCT04642807 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Long arm soft cast
Description: Participants in group 2 will have a long arm soft cast applied without clinical or radiological follow up.
Study NCT04642807 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Long arm full cast
Description: Participants in group 1 will have a long arm full cast applied.
Study NCT05172960 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAPIEN X4 THV
Description: Implantation of the SAPIEN X4 valve
Study NCT04830566 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release technique
Description: Myofascial technique on the thoracolumbar fascia and lumbar paraspinal muscles
Study NCT04830566 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Simulated Myofascial Release technique
Description: Superficial hands contact on the lumbar area
Study NCT04722029 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adenovirus Specific T lymphocytes
Description: ADV-VSTs is being proposed for the treatment of refractory ADV infection and/or disease in these populations using haploidentical donors for ease of donor selection, antiviral immunity, coupled with a high-throughput antigen stimulation/IFN-γ capture system (Miltenyi Biotec, CliniMACS Prodigy® System) for rapid and less costly isolation of ADV-VSTs.
Study NCT05414851 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Description: Participants will consume two weeks of each diet, with a 4-6 week washout period in between. Meals and snacks are provided for convenience to enhance adherence to each dietary pattern, but subjects can add or include their own home-prepared foods as long as they meet dietary guidelines. Each dietary intervention will include an education session via Zoom teleconference, and at least 2 individual contacts by phone to address questions and assess for adverse events.
Study NCT06448052 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: umbilical cord mesenchymal stem cell
Description: A total of 100 million single cells were suspended in 0.9% sterile saline solution and given intravenously at a 5-ml/min rate for 45 min. All patients will get two intravenous autologous infusions on days 0 (D0) and 90 (D90).
Study NCT06188897 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-stretching of the masticatory musculature
Description: If the subject belonged to the Treatment group, he was instructed to self-stretch the masticatory muscle.~This stretch consisted of introducing three knuckles of the non-dominant hand between the incisors for two minutes while sitting.
Study NCT06188897 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control group intervention
Description: The control group was asked to introduce only two knuckles in the oral cavity and perform a mandibular occlusion, an intervention that serves as a simulated stretch in said group.
Study NCT04777370 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: posterior glide mobilization
Description: The participant will be positioned supine on a plinth, with their scapula stabilized against a firm wedge on the table, and the shoulder joint in the resting position (approx. 55 degrees abduction, 30 degrees horizontal adduction, and slight external rotation). With the extremity held in the same position, the researcher will then apply a grade III (into tissue stretch) PG mobilization. This will consist of five 30-second bouts of sustained gr III posterior glide mobilizations.
Study NCT04777370 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sleeper stretch
Description: All participants randomized to the stretching group will perform five 30-second holds of the sleeper stretch. This is performed by lying on the side to be stretched, elevating the upper arm to 90° on the support surface with the elbow bent 90°, then passively internally rotating the shoulder with force provided by with the opposite arm.